Dr. Reddy's is a big Indian generic drugmaker.
Dr. Reddy's Laboratories Limited (RDY) is expected to report earnings on Friday, October 23, 2026, after the close. Consensus EPS estimate is $0.10.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-21 | Jun 2026 qtr | $0.09 | $0.06 | — | $835.68M |
| 2026-05-12 | Mar 2026 qtr | $0.09 | $0.06 | — | $785.89M |
| 2026-01-21 | Dec 2025 qtr | $0.16 | $0.16 | +1.7% | — |
| 2025-10-24 | Sep 2025 qtr | $0.19 | $0.20 | +2.3% | — |
| 2025-06-30 | Jun 2025 qtr | $0.21 | $0.20 | -6.7% | $997.48M |
| 2024-09-30 | Sep 2024 qtr | $0.21 | $0.04 | — | $954.28M |
| 2024-06-30 | Jun 2024 qtr | $0.19 | $0.20 | +4.0% | $920.72M |
| 2023-06-30 | Jun 2023 qtr | $0.15 | $0.21 | — | $821.16M |
RDY has beaten consensus EPS in 3 of its last 4 scored quarters.
See RDY on the live calendar →